PURA - Puration Is Expanding CBD Beverage Bottling Internationally
November 06 2019 - 02:25PM
InvestorsHub NewsWire
Dallas, TX -- November 6, 2019 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today confirmed plans to begin producing CBD beverages in
Europe. Earlier this week, PURA announced executing a letter
of intent to acquire a company headquartered in Germany as part of
a strategy to bottle PURA’s CBD infused beverages locally.
The German LOI follows PURA recently signing a
distribution
agreement in
Europe for its EVERx CBD Sports Water with other CBD infused
beverages to follow. The initial European distribution
agreement is estimated to add $4 million in sales next year.
Management indicates that the potential of European distribution
beyond the initial $4 million projection warrants the establishment
of a local bottling capacity. The European market for CBD is
project to reach nearly US $17 billion
by 2023. Today the company reveals that the
bottling expansion in Europe is part of a bigger plan to expand
bottling in Canada and Latin America. PURA is actively
developing acquisition opportunities similar to the one developing
in Germany.
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2023 to Mar 2024